Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactated Ringer's solution with rectal indomethacin for prevention of post-ERCP pancreatitis
PACTR202201712208274Not yet recruiting
- Sponsor
- Hôpital Militaire Mohamed Seghir Nekkache
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of lactated ringer's solution and indomethacin in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by Hôpital Militaire Mohamed Seghir Nekkache. Primary endpoint: Post-ERCP pancreatitis. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
lactated ringer's solutionindomethacin
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on PACTR202201712208274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202201712208274.